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ABSTRACT 14 
Extra-fetal tissues are a non-controversial and inexhaustible source of mesenchymal stem cells 15 
(MSCs) that can be harvested non-invasively at low cost. In the veterinary field, as in man, stem 16 
cells derived from extra-fetal tissues express plasticity, reduced immunogenicity, and have high 17 
anti-inflammatory potential making them promising candidates for treatment of many diseases. 18 
Umbilical cord mesenchymal cells have been isolated and characterized in different species, and 19 
have recently been investigated as potential candidates in regenerative medicine. In this study, cells 20 
derived from bovine Wharton’s jelly (WJ) were isolated for the first time by enzymatic methods, 21 
frozen/thawed, cultivated for at least ten passages and characterized. Wharton’s jelly (WJ)-derived 22 
cells readily attached to plastic culture dishes displaying typical fibroblast-like morphology and, 23 
although their proliferative capacity decreased to the seventh passage, these cells showed a mean 24 
doubling time of 34.55 ± 6.33 hours and a mean frequency of 1 colony forming unit fibroblast-like 25 
(CFU-F) for every 221.68 plated cells. The results of molecular biology studies and flow cytometry 26 
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analyses revealed that WJ-derived cells showed the typical antigen profile of MSCs and were 27 
positive for CD29, CD44, CD105, CD166, Oct-4 and c-Myc. They were negative for CD34 and 28 
CD14. Remarkably, WJ-derived cells showed differentiation ability. After culture in induced media, 29 
WJ-derived cells were able to differentiate into osteogenic, adipogenic, chondrogenic and 30 
neurogenic lines as shown by positive staining and expression of specific markers. On PCR 31 
analysis, these cells were negative for MHC-II and positive for MHC-I, thus reinforcing the role of 32 
extra-fetal tissue as an allogenic source for bovine cell-based therapies. These results provide 33 
evidence that bovine WJ-derived cells may have the potential to differentiate to repair damaged 34 
tissues and reinforce the importance of extra-fetal tissues as stem cell sources in veterinary 35 
regenerative medicine. A more detailed evaluation of their immunological properties is necessary to 36 
better understand their potential role in cellular therapy. 37 
 38 
Key words: bovine, Wharton’s jelly, stromal cells, characterization 39 
 40 
1. INTRODUCTION 41 
Increasing interest in veterinary stem cell therapy has led to research into new stem cell sources that 42 
can supply sufficient numbers of cells whilst minimizing risks to donors and recipients [1]. Extra-43 
fetal stem cells are being investigated for this purpose in large animals [2]. Extra-fetal stem cells 44 
have been isolated from umbilical cord blood, amniotic fluid, amniotic membrane, umbilical cord 45 
matrix, yolk sac and placenta [3-9]. It has been shown that they possess properties of mesenchymal 46 
stem cells, and their application in regenerative medicine has increased over the past few years [10]. 47 
These studies show that umbilical cord, previously considered as a biomedical waste, is a source of 48 
stem cells with promising therapeutic applications in man as well as in livestock species.  49 
The umbilical cord provides an inexhaustible source of stem cells and presents few, if any, ethical 50 
concerns. Indeed, umbilical cord can be collected after parturition since it is considered a waste 51 
tissue. In addition, the process of obtaining the cord tissue is relatively simple and non- invasive. 52 
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Mesenchymal stem cells (MSCs) have been isolated from different compartments of the umbilical 53 
cord in different species. In particular, they were obtained invasively, by a surgical intrauterine 54 
approach, from umbilical cord blood of sheep [11,12], non-invasively at the time of birth in the 55 
horse [13], in cattle, after caesarean section delivery [14], and from canine and feline fetuses at birth 56 
[15,16]. In 2006, for the first time in veterinary medicine, MSCs from cordon matrix, called 57 
Wharton’s jelly (WJ), were obtained from porcine umbilical cord [17]. Wharton’s jelly is the 58 
embryonic mucous connective tissue lying between the amniotic epithelium and the umbilical 59 
vessels [18]. It encloses the yolk sac, which is the source of primordial germ cells and the first 60 
hematopoietic stem cells [18]. Extra-embryonic tissues, which originate from the hypoblast and the 61 
trophectoderm, do not participate in gastrulation, therefore they are less differentiated than adult 62 
somatic tissues such as bone marrow or adipose tissue [2]. Wharton’s jelly is a rich source of MSCs 63 
[19-21]. Recently, primitive MSCs were isolated from the umbilical cord matrix in caprine [22,23], 64 
canine [24] and equine species [4,13,25]. These cells show specific markers of pluripotency and 65 
MSCs markers and are able to differentiate into adipogenic, chondrogenic, osteogenic and 66 
neurogenic tissues [2]. The similarities in growth kinetics and expression of markers of pluripotency 67 
indicate their close resemblance to embryonic stem cells [26]. These markers, found in mouse and 68 
human embryonic stem cells, include the POU (Pit/Oct/Unc) domain-containing protein Oct-4, Sox-69 
2 and Nanog. Some authors have shown that human umbilical cord matrix expresses low levels of 70 
transcription factors that play a central role in the regulation of pluripotency and self-renewal [18]. 71 
In contrast however, Carlin et al. [17] showed that cells derived from porcine umbilical cord matrix 72 
express markers of embryonic lineage Oct-3/4, Sox2 and Nanog. Contrary to observations in adult 73 
MSCs, WJ-MSCs share properties unique to fetal-derived MSCs, such as more rapid proliferation 74 
and greater ex vivo expansion capabilities [18,27]. Moreover, they have high potential to be 75 
differentiated in vitro [28], they express HLA-class I surface markers but do not express HLA-class 76 
II markers [29], and they are immunosuppressive in mixed lymphocyte assays by inhibition of T-77 
cell proliferation [30,31]. For these reasons, these cells have raised interest for their potential uses in 78 
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cell and gene therapy, cloning, virological and biotechnological studies [32]. 79 
Despite the importance of bovine species as models for in vivo studies, little it is known about 80 
bovine MSCs. So far, they have been derived from umbilical cord blood [14], bone marrow [33,34] 81 
and amniotic membrane or amniotic fluid [8]. To date, only one paper on isolation and 82 
characterization of MSCs from bovine umbilical cord matrix [32] had been published but these cells 83 
were isolated by migration techniques and not by classical enzymatic digestion. The mechanical and 84 
enzymatic disaggregation of the tissue avoids problems of selection by migration, but perhaps more 85 
importantly, yields a higher number of cells more representative of the whole tissue in a shorter 86 
time. However, as well as the primary explant technique selecting on the basis of cell migration, the 87 
dissociation technique selects cells resistant to disaggregation but still capable of attachment [35]. 88 
The isolation of bovine MSCs from fetal adnexa is an interesting prospect because of the potential 89 
for these cells to be used for biotechnological applications. For the first time, we isolated, by 90 
enzymatic methods, presumptive MSCs from bovine WJ and were able to characterize them in 91 
terms of morphology, specific mesenchymal or pluripotent markers, proliferative and differentiation 92 
potential.  93 
 94 
2. MATERIALS AND METHODS 95 
2.1 Materials 96 
Chemicals were obtained from Sigma Chemical (Milan, Italy) and tissue culture plastic dishes from 97 
Euroclone (Milan, Italy) unless otherwise specified. 98 
 99 
2.2 Tissue collection 100 
This study was approved by the Ethical Committee of the University of Milan and written owner 101 
consent was given. All procedures were conducted following standard veterinary practice and in 102 
accordance with 2010/63 EU directive on animal protection and Italian Law (D.L. No. 116/1992). 103 
Fresh bovine umbilical cords were obtained after full-term births.  104 
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Bovine umbilical cords (n=3) were obtained from three cows following normal term pregnancies 105 
with spontaneous parturition in accordance with veterinary practice standard. Before the cows stood 106 
up breaking the cord, a surgical tape was placed at the calf junction and a second tie was tightened 107 
at approximately 30/40 cm from the first. The tie-limited cord portion was cut away with scissors. 108 
The harvested segment of the cord was washed twice in sterile saline solution and kept at 4°C in 109 
saline solution supplemented with 4 µg/mL amphotericin, 100 UI/mL penicillin and 100 µg/mL 110 
streptomycin and processed within 12 hours of collection.  111 
 112 
2.3 Isolation and culture of WJ-derived cells 113 
At the laboratory, the loose amnion was removed from the exterior of the cords and the cords were 114 
incised longitudinally to expose and remove umbilical vessels (arteries and veins). The remaining 115 
WJ-containing tissue was minced into small pieces using scissors. The tissue was digested in HG-116 
DMEM supplemented with 1mg/mL collagenase type I at 38.5 °C for 8 hours. After incubation, 117 
collagenase was inactivated by diluting 1:1 with HG-DMEM supplemented with 10% fetal calf 118 
serum (FCS). The digested suspension was filtered on an 80 µm strainer, centrifuged at 300 g for 10 119 
minutes and washed twice in PBS. Before seeding, cells were counted using a Burker chamber with 120 
the Trypan Blue dye exclusion assay. WJ-cell cultures were established in HG-DMEM standard 121 
medium composed of 10% FCS, penicillin (100 UI/mL)-streptomycin (100 µg/mL), 0.25 µg/mL 122 
amphotericin B, 2 mM L-glutamine and 10 ng/mL EGF. Cultures were established at a density of 123 
1x105 cells/cm2 in T75 culture flasks. The flasks were incubated at 38.5 °C with 5% CO2 and 90% 124 
humidity. The medium was replaced after 72 hours to remove non-adherent cells and then replaced 125 
twice weekly until cells reached approximately 80% confluence. Cells were then detached with 126 
0.05% trypsin-EDTA, counted, and redistributed into new culture flasks at a density of 1x104 127 
cells/cm2 to maintain and expand the culture for ten passages (P).  128 
 129 
 130 
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2.4 Cryopreservation and thawing 131 
Cells at P3 were cryopreserved. Briefly, the confluent cultures were treated with 0.05% trypsin-132 
EDTA and washed by centrifugation (200g at 4 °C, for 5 minutes) with cell culture medium 133 
supplemented with 10% FCS to neutralize trypsin-EDTA. The cell pellet obtained was resuspended 134 
in pre-cooled (4 °C) cryopreservation media in 1-mL cryovials. The cryopreservation medium was 135 
90% (v/v) FBS and 10% dimethyl sulfoxide. The cryovials were maintained at -80 °C overnight and 136 
then plunged into liquid nitrogen (-196 °C). After a minimum of one month of cryopreservation, the 137 
cells were thawed in a water bath at 37 °C. The cells were diluted in culture medium and 138 
centrifuged twice at 200g for 10 minutes. The cell pellet was resuspended in culture medium and 139 
plated in T25 culture flasks. Aliquots of these cells were kept to evaluate the cell viability using 140 
Burker hemocytometer chamber using the trypan blue dye exclusion method, under phase contrast 141 
microscopy (Nikon Eclipse Ti, Tokyo, Japan). After thawing, other aliquots were used for 142 
population doubling studies, or expanded until P3 to evaluate specific MSC marker expression and 143 
multipotent differentiation capacity in comparison to freshly isolated cells. 144 
 145 
2.5 Proliferation rate and CFU-assay 146 
Proliferation of MSCs was determined as previously reported [6]. Doubling time (DT) from P 1-10 147 
was assessed by plating 9x103 cells into six-well tissue culture plates. Every 4 days, cells were 148 
trypsinized, counted and reseeded at the same density. Mean DT was calculated from day 0 to day 149 
4. The DT value was obtained for each P according to the formula DT=CT/CD, where CT 150 
represents the culture time and CD=log(Nc/No)/log2 represents the number of cell generations (Nc 151 
represents the number of cells at confluence, No represents the number of seeded cells). Data 152 
representative of three independent experiments are reported.  153 
To obtain the cell proliferation growth curve, cells at P0, P3 and P5 were seeded into six-well tissue 154 
culture dishes at a density of 1 × 103 cells/cm2. Every 2 days, until 14 days of culture, one well out 155 
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of the six was trypsinized and cells were counted using the Trypan blue dye exclusion method with 156 
a Burker chamber. 157 
Colony-forming unit (CFU) assays were performed at P0 on freshly isolated cells at different 158 
densities (100, 250, 500 and 1000 cells/cm2). Cells were plated in six-well plates for two weeks in 159 
HG-DMEM standard medium. Then, colonies were fixed for 1 hour with 4% formalin and stained 160 
with 1% methylene blue for 15 minutes in 10 mM borate buffer at room temperature. Colonies 161 
formed by 16 to 20 nucleated cells were counted under a BX71 microscope (Olympus Italia, Srl, 162 
Milano, Italy). 163 
 164 
2.6 Osteogenic, adipogenic, chondrogenic and neurogenic cell differentiation  165 
All the differentiation tests were performed when cells reached P3. 166 
For osteogenic differentiation, cells were placed in plastic six-well plates at a density of 28 x103 167 
cells per well. After the cells had adhered to the plastic, the inducer medium was added to the plate 168 
for 21 days and refreshed every three days. The medium was composed of HG-DMEM, 10% FCS, 169 
penicillin (100 UI/mL)-streptomycin (100 µg/mL), 0.25 µg/mL amphotericin B, 200 mM L-170 
glutamine, 0.25 mM ascorbic acid, 10 mM β-Glycerophosphate, and 0.1 uM Dexamethasone [36]. 171 
Osteogenic differentiation was confirmed by positive staining of the extracellular calcium matrix 172 
using Von Kossa staining. 173 
For adipogenic differentiation, cells were placed in plastic six-well plates at a density of 28 x103 174 
cells per well. After the cells had adhered to the plastic, the inducer medium and the maintaining 175 
medium were added alternately, every 3 days for a total of 21 days. The inducer medium was 176 
composed of HG-DMEM, 10% FCS, penicillin (100 UI/mL)-streptomycin (100 µg/mL), 0.25 177 
µg/mL amphotericin B, 200 mM L-glutamine, 0.1% insulin, 0.1 uM dexamethasone, and 1% 178 
indomethacin. The maintaining medium was composed of HG-DMEM, 10% FCS, penicillin (100 179 
UI/mL)-streptomycin (100 µg/mL), 0.25 µg/mL amphotericin B, and 0.1% insulin [36]. Adipogenic 180 
differentiation was confirmed by positive staining of the lipid structures using Oil Red O staining. 181 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
For chondrogenic differentiation, cells were cultured in DMEM low-glucose, containing 100U/mL 182 
penicillin, 100 µg/mL streptomycin, 0.25 µg/mL amphotericin B, 2 mM/l L-glutamine, 100 nM 183 
dexamethasone, 50 µg/mL L-ascorbic acid 2-phosphate, 1 mM sodium pyruvate (BDH, Atlanta, 184 
USA), 40 µg/mL proline, ITS (insulin 5 µg/mL, transferrin 5 µg/mL, selenous acid 5 ng/mL) and 5 185 
ng/mL transforming growth factor-β3 (Peprovet, DBA Italia, 100-36E). Chondrogenic 186 
differentiation was assessed after incubating cells for up to 3 weeks [37].  Differentiation was 187 
evaluated by Alcian blue staining. 188 
For neurogenic differentiation, cells were placed in plastic six-well plates at a density of 28 x103 189 
cells per well. After the cells had adhered to the plastic, the pre-inducer medium was administrated 190 
to the plates for 1 day, followed by administration of inducer medium for 7 days. The pre-inducer 191 
medium was composed of HG-DMEM, 20% FCS, penicillin (100 UI/mL)-streptomycin (100 192 
µg/mL), 0.25 µg/mL amphotericin B, and 0.0007% β-mercaptoethanol [15,38]. The inducer 193 
medium was composed of HG-DMEM, 2% FCS, penicillin (100 UI/mL)-streptomycin (100 194 
µg/mL), 0.25 µg/mL amphotericin B, 1% DMSO, and 0.36 mg/mL BHA [39]. Neurogenic 195 
differentiation was confirmed by positive staining of the Nissl substance and granules, using Nissl 196 
staining. 197 
For each differentiation experiment, a control group was performed by seeding cells at lower 198 
density (9.5x103) and feeding with HG-DMEM standard medium. These cells were stained using 199 
the same protocol as the treated cells. At the end of the differentiations, aliquots of non-stained cells 200 
were harvested and stored at -80 °C for further molecular analysis. 201 
 202 
2.7 RNA extraction and Reverse Transcription-PCR analysis  203 
Expression of specific MSC (CD29, CD44, CD105, CD166), pluripotent- (Oct-4 and c-Myc) and 204 
hematopoietic (CD34, CD14, CD45) markers was investigated by RT-PCR analysis on fresh and 205 
thawed undifferentiated cells at P3. To evaluate whether cells could be well tolerated by the host 206 
once transplanted, expression of the Major Histocompatibility Complex, class I (MHC-I) and II 207 
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(MHC-II) was assessed. Total RNA was extracted from bovine WJ-derived cells using Trizol 208 
reagent (Invitrogen, Monza, Italy), followed by DNase treatment according to the manufacturer’s 209 
specifications. RNA concentration and purity were measured using a NanoDrop ND1000 210 
spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). cDNA was synthesized from 211 
500 ng total RNA, using the iScript retrotranscription kit (Bio-Rad Laboratories, Hercules, CA, 212 
USA). Conventional PCR was performed in a 25 mL final volume with DreamTaq DNA 213 
Polymerase (Fermentas, St. Leon Rot, Germany) under the following conditions: initial 214 
denaturation at 95 °C for 2 minutes, 32 cycles at 95 °C for 30 seconds (denaturation), 55–63 °C for 215 
30 seconds (annealing), 72 °C for 30 seconds (elongation) and final elongation at 72 °C for 10 216 
minutes.  217 
For differentiation experiments, total RNA was extracted from undifferentiated (control cells) and 218 
from induced WJ-derived cells and RT-PCR analysis was performed as described above. Bovine 219 
adult tissues (bone, fat, cartilage and spinal cord) were employed as positive controls for assessing 220 
the expression of BGLAP, SPP1 and SPARC for osteogenic differentiation, peroxisome proliferator- 221 
activated receptor-gamma (PPAR-y), and leptin (LEP) for adipogenesis, collagen type 2α1 222 
(COL2A1) and aggrecan (ACAN) for chondrogenesis, and glial fibrillary acidic protein (GFAP) and 223 
nestin (NES) for neurogenesis. Bovine-specific oligonucleotide primers were designed using open 224 
source PerlPrimer software v. 1.1.17, based on available NCBI Bos taurus sequences or on Mammal 225 
multi-aligned sequences. Primers were designed across an exon–exon junction in order to avoid 226 
DNA amplification. Primers were used at 300 nM final concentrations. Their sequences and the 227 
conditions used to amplify each gene are shown in Table 2. GAPDH was employed as a reference 228 
gene. 229 
 230 
2.8 Flow cytometry 231 
WJ-derived cells were analyzed by flow cytometry to determine the percentage of mesenchymal-232 
(CD105, CD166), hematopoietic (CD34) and immunogenic (MHC-II) markers after isolation (P0). 233 
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For CD105, CD166 and CD34, primary mouse monoclonal antibodies and secondary antibodies 234 
rabbit anti-mouse FITC (Sigma, Milan, Italy) were used. For MHC-II, primary rat monoclonal 235 
antibody and secondary rabbit anti-rat FITC (Sigma) were used. Staining was performed as 236 
previously reported [40]. Cells (1x106 cells/mL) were labeled with primary antibodies in PBS with 237 
3% of bovine serum albumin (BSA) (BDH; VWR International Ltd, Poole, UK) for 45 minutes at 238 
room temperature in the dark, followed by washing in cold PBS and a final incubation with 239 
secondary antibodies (1:50) for 30 minutes at room temperature in the dark. After incubation, cells 240 
were washed twice in ice-cold PBS and analyzed using a Millipore Guava easyCyte Single Sample 241 
Flow Cytometer. A minimum of 10,000 cells was acquired for each sample and analyzed in the FL1 242 
channel.  243 
The negative pattern was examined by applying the same cell suspension with the first incubation, 244 
and the result was included on the global compensation, in order to exclude auto fluorescence. A 245 
488 nm filter was used in each analysis. 246 
Off-line analyses of the flow cytometry standard (FCS) files were performed using Weasel software 247 
v.2.5 (http://en.bio-soft.net/other/WEASEL.htmL). 248 
 249 
2.9 Statistical analysis  250 
Statistical analysis was performed using GraphPad Instat 3.00 for Windows (GraphPad Software, 251 
La Jolla, CA, USA). Three replicates were performed for each experiment (DT and CFU) and the 252 
results reported as mean ± standard deviation (SD). One-way analysis of variance (ANOVA) for 253 
multiple comparisons by Student-Newman-Keuls multiple comparison tests was used. P<0.05 was 254 
considered as significant. 255 
 256 
3. RESULTS 257 
3.1 Cell morphology 258 
The cellular yield was approximately 3x106 cells per gram of minced WJ. The initial viability was 259 
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greater than 95%. 260 
Cells were selected purely on their ability to adhere to plastic. Isolated cells readily attached to 261 
plastic culture dishes. Colonies started to appear within the first two days, reaching confluence after 262 
5 days. WJ-derived cells were a morphologically homogeneous population of fibroblast-like cells in 263 
all passages of cell culture (Figure 1 A).  264 
After thawing (at P3), viability was 80%. WJ-derived cells conserved their fibroblast-like shape. 265 
 266 
3.2 Proliferation studies Cells WJ-derived cells were able to proliferate, reaching confluence in up 267 
to 10 passages.  268 
At P1, the growth curve showed an initial lag phase of 3-4 days longer than that seen in the other 269 
passages and a subsequent log phase until 14 days. The WJ-derived cells showed more extensive 270 
proliferation at P5 but the intensity of proliferation was similar in all passages in the final culture 271 
days (Fig 1B). 272 
DT remained constant until the seventh passage, then decreased significantly (P<0.05) until passage 273 
10. The mean DT was 1.44 ± 0.24 days or 34.55 ± 6.33 hours (Fig 1C).  274 
After thawing, the mean DT was 1.59 ± 0.06 days or 38.21 ± 1.68 hours (Fig 1C) with no statistical 275 
difference compared to fresh cells. 276 
The number of cell colonies formed was counted at P0 on fresh cells. These cells were able to form 277 
an average of 1 CFU-F) (Fig 1D) for 221.68 ± 3.86 seeded cells. The highest number of colonies 278 
was found at the greatest density of seeding (Table 1).  279 
 280 
3.3 Molecular characterization 281 
As shown by RT-PCR, WJ-derived cells expressed MSC-markers (CD29, CD44, CD105, CD166) 282 
and lacked hematopoietic ones (CD34 and CD14) from P0 to P10. MHC-I expression was present 283 
while MHC-II was not. Moreover, undifferentiated MSCs were found to express Oct-4 and c-Myc, 284 
essential transcription factors for maintaining the primitive pluripotent state of embryonic stem 285 
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cells. After thawing, cells studied at P3 expressed the same MSC-mRNA markers such as CD29, 286 
CD44, CD105, CD166, Oct-4, c-Myc and MHC-I, as freshly isolated cells, but not CD34, CD14 and 287 
MHC-II. (Figure 2A).  288 
 289 
3.4 Flow cytometry analysis 290 
Flow cytometry was used to evaluate the homogeneity of the cell population and to identify the 291 
subset of mesenchymal, hematopoietic and immunogenic cells. The cell populations tested were all 292 
CD105+ and CD166+, but negative for CD34 and MHC-II, as shown in Fig 2B. 293 
 294 
3.5 Differentiation assay 295 
The results of all differentiation assays are shown in Fig 3. 296 
Osteogenic differentiation potential. After 21 days of induction, osteogenic differentiation was 297 
confirmed by von Kossa staining. The control (non-induced cells) was negative for von Kossa 298 
staining. RT-PCR analysis of SPP1 and SPARC mRNA expression confirmed osteogenic induction 299 
but BGLAP was not expressed in induced cells. 300 
Adipogenic differentiation potential. Cells were able to undergo adipogenic differentiation, as 301 
demonstrated by the development of positive staining for Oil Red O after 3 weeks of culture in 302 
adipogenic induction medium. Control cells, maintained in regular control medium, showed no lipid 303 
deposits. RT-PCR analysis of PPAR-y and LEP mRNA expression confirmed adipogenic induction. 304 
Chondrogenic differentiation potential. Differentiation was identified by marked deposition of 305 
glycosaminoglycans in the matrix, stained with Alcian blue. The presence of COL2A1 and ACAN 306 
mRNA confirmed chondrogenic induction for this cell population. 307 
Neurogenic differentiation potential. After 3 days of induction, neurogenic differentiation was 308 
confirmed by the morphology of the cells. The WJ-derived cells adopted the typical morphology of 309 
neural cells with dendrite-like processes. The presence of GFAP mRNA suggested that under these 310 
culture conditions, WJ-derived cells were induced to differentiate into glial cells. RT-PCR analysis 311 
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of bovine adult tissues (bone, fat, cartilage and spinal cord) showed expression of the specific 312 
studied genes. 313 
The frozen-thawed cells were able to differentiate toward the same lineages as freshly isolated cells 314 
(data not shown). 315 
 316 
4. DISCUSSION 317 
This work allowed the isolation, characterization and differentiation of bovine stem cells derived 318 
from WJ. Our findings suggest that this tissue is a reliable source of presumptive stem cells, 319 
displaying intermediate features between adult and embryonic stem cells. These cells havewide 320 
potential clinical applications, because of their low immunogenicity and high differentiation 321 
potential. After digestion, large numbers of WJ-derived cells with > 95% viability (optimal value in 322 
terms of plating efficiency and cellular growth) were obtained. When cultured, these cells 323 
demonstrated strong adherence to plastic dishes and developed fibroblast-like morphology over 324 
time. Adherence is a fundamental property for the culture of stem cells [41]. The proliferation 325 
studies showed that WJ-derived cells reached high plating efficiency and had a high proliferation 326 
rate in vitro until P10, demonstrating a growth curve with a lag phase of few hours and an intensive 327 
log phase of 12 days. Moreover, the mean value of DT for 10 passages was 34.55 hours. During this 328 
intensive proliferation, the cells maintained their morphological characteristics. These data are in 329 
agreement with those obtained by other researchers who reported a high proliferation rate of human 330 
[37,42], equine [6], bovine [8] and feline [43] extra-fetal derived cells. It is very difficult to 331 
compare these data with those obtained from Cardoso et al. [32] because this study only reported 332 
the number of cells per mL found at different passages and the DT value was not calculated. 333 
Bovine WJ-derived cells also showed the ability to produce clones. When seeded at different 334 
densities, they were able to form clones with a frequency that increased with the cell-seeding 335 
density, suggesting paracrine signaling between cells at P0 [44]. Moreover, WJ-derived cells 336 
showed a typical expression pattern expected for cultured stem cells [41] when analyzed by RT-337 
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PCR. Indeed, these cells expressed a pattern of mesenchymal (CD29, CD44, CD105, CD73, 338 
CD166) and pluripotency (Oct4, c-Myc) genes with no expression of the hematopoietic CD34. The 339 
pluripotency genes are essential transcription factors for maintaining the primitive pluripotent state 340 
of embryonic stem cells. These data confirm the results obtained in equine, canine and bovine WJ 341 
[6,8,24,32,45-47] where pluripotent- and mesenchymal-associated markers were expressed.  342 
For the first time, the expression of MHC-I and MHC-II, related to cell immunogenicity, was also 343 
evaluated to assess the usefulness of bovine WJ-derived cells for cell therapy. At each passage, 344 
these cells were negative for MHC-II and positive for MHC-I, consistent with findings of previous 345 
publications [6,8]. These findings reinforce the role of the extra-fetal tissue as an allogenic source 346 
for cell-based therapies in cattle. It is important to underline that RT-PCR alone is not useful for 347 
characterizing WJ-derived cells and that quantitative analyses are needed to make meaningful 348 
statements about their gene expression. Flow cytometry provides useful quantitative data on the 349 
percentage of cell reactivity. Indeed, we showed that >90% cells were positive for CD105 and 350 
CD73 while < 10% were positive for CD34 and MHC-II. These data confirm the mesenchymal 351 
nature of isolated cells, the lack of immunogenicity and underline the homogeneity of this cell line.  352 
The capacity of MSCs to differentiate into a variety of cell types (adipocytes, osteocytes and 353 
chondrocytes) [48,49], has aroused interest in cell and gene therapy. Bovine WJ-derived cells, 354 
obtained by enzymatic digestion, were able to differentiate into osteocytes, adipocytes, 355 
chondrocytes and neuron-like cells in the same way as cells obtained by non-enzymatic digestion 356 
[32]. This suggests that these cells are capable of differentiation into multiple germ layers, an 357 
essential characteristic also observed in the pig [17], dog [24], horse [4] and chicken [50]. After 21 358 
days of induction, mineral deposits were confirmed by Von Kossa staining and by the expression of 359 
SPP1 and SPARC but not of BGLAP. This might be because BGLAP is expressed in terminally 360 
differentiated osteoblasts [51]. When stimulated to differentiate towards the adipogenic lineage, 361 
bovine WJ-derived cells were positive for Oil Red O staining and expressed genes involved in lipid 362 
biosynthesis and storage. mRNAs for PPAR-γ, crucial for the preadipocyte commitment [52], and 363 
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LEP, regarded as a late marker of adipocyte differentiation, were detected. The potential of bovine 364 
WJ-derived cells to undergo chondrogenesis was confirmed by positive Alcian blue staining and 365 
identification of markers commonly associated with the chondrocyte phenotype such as collagen 366 
type II and aggrecan, the most essential cartilage proteoglycan and key markers of chondrocyte 367 
differentiation [53]. ACAN expression was demonstrated, whereas a basal level of COL2A1 was 368 
detected. The low expression of COL2A1 might be related to the culture conditions in this study 369 
since chondrogenic differentiation of MSCs in monolayer culture appears to be dose-dependent and 370 
time-dependent in relation to the bioactive factors used [32,33]. GFAP and nestin, markers, 371 
expressed in neuronal precursor stem cells, have been detected in WJ-derived cells. The expression 372 
of both markers is probably related to the ability of these cells to differentiate either towards the 373 
glial cell lineage, as previously shown by Miki et al. [54] for 95% of cells isolated from human 374 
amnion, or toward neurogenic line as previously observed in pigs [55].  375 
Whatever the reason, this cell line converted into a typical neuron-like morphology when 376 
appropriately induced.  377 
Our findings suggest that, in agreement with reports of other researchers in several species [6,45-378 
47,56], bovine WJ represents an alternative source of progenitor cells, that can be obtained by 379 
enzymatic methods for use in cell-based therapies. In our study, the digestion of tissue did not result 380 
in a reduced cellular viability or degradation of cellular surface receptors or alteration of cellular 381 
function as reported by Jeschke et al. [57].  382 
Moreover, after thawing, the cryopreserved cells had a high level of viability (80%) and could be 383 
successfully expanded and differentiated. This demonstrates that bovine umbilical cord matrix cells 384 
can tolerate freezing without loss of functional integrity in terms of morphology, presence of 385 
specific stemness markers and differentiation potential, although renewal capacity was slightly 386 
lower than that observed in freshly isolated cells. 387 
In conclusion, these data confirm that bovine WJ contain a niche of MSCs. However, further 388 
investigation, including pre-clinical studies and further study of immunological properties, are 389 
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needed to better understand their role in cellular therapy before in vivo applications of WJ-derived 390 
cells are considered. To date, there is only a single literature report of transplantation of caprine WJ-391 
derived cells for wound healing, which showed promising effects [23]. The findings of this study 392 
reinforce the emerging importance of extra-embryonic tissues for derivation of cells that may be 393 
ideal tools in veterinary regenerative medicine. 394 
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Table 1. CFU assay 633 
 634 
Density cells/cm2 Total cells CFU 
1 CFU 
each 
100 950 1.5±0.71a 633.33 
250 2375 22.33±5.17b 106.36 
82.01 500 4750 57.92±4.31c 
1000 9500 146.15±2.78c 65.00 
Different small letters superscripts (a,b,c) indicate statistically different comparisons (P<0.05) between cell densities in 635 
the WJ group. 636 
 637 
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Table 2. Oligonucleotide sequences used for RT-PCR analysis. 638 
 639 
Markers Forward (5’3’) Reverse (5’3’) Annealing T Product 
lenght 
Integrin β-1 (CD29) GTTGGTTCTGCAGTTACGATCAG AACCAAACCCAATTCGGAAGTC 52°C 203 
CD44 antigen (CD44) AACAGTAGGAGAAGGTGTGG TCATGAACTGGTCTTGGGTC 61°C 166 
Endoglin (CD105) ACAAGTCTTGCAGAAACAGTC GATGTCTGGAGAGTCAGCTC 61°C 182 
ALCAM (CD166) GTATTTATTGCCTTCAGGTCCT TCTACCAGGGAGCATTTATAGTC 59°C 755 
octamer-binding transcription factor 4 (Oct-4) CACACTAGGATATACCCAGGC GGAGATATGCAAGGCAGAGA 60°C 177 
v-myc avian myelocytomatosis viral oncogene homolog (c-Myc) GCGCCGCATTCGCGAAACTT TGAGGGGCATCGCTGCAAGC 58°C 214 
CD34 molecule (CD34) 
CD14 molecule (CD14) 
CCTGAAGCTAAATGAGACCT 
TCCGAAGCCTGACTGGTCTA 
AACTTTCTGTCCTGTTGGTC 
TGTCGGCTCCCTTGAGAAAC 
58°C 
56°C 
173 
 
104 
Major histocompatibility complex I (MHC-I) GATCTCACTGACCTGGCA CTGAGGAGGTTCCCATCTC 60°C 199 
Major histocompatibility complex II (MHC-II) CCTCGCTTGCCTGAATTTGC ACAGGTGCCGACTGATGC 53°C 299 
Bone Gamma-Carboxyglutamate (Gla) Protein (BGLAP) TCGGGCAAAGGCGCAGCCTTC GCAGGGCTGCAAGCTCTAGACG 55°C 231 
Secreted Phosphoprotein 1 (SPP1) 
 
CGCCGATCTAACGTTCAGAGTC GACTCTCAATCAGATTGGAATGC 55°C 199 
secreted protein acidic and rich in cysteine (SPARC) 
 
CTGGTCACGCTGTACGAGAG CGGTGTGAGACAGGTACCCGT 55°C 232 
Leptin (LEP) CAATGACATCTCACACACGCAG CGGCCAGCAGGTGGAGAAG 55°C 212 
Peroxisome Proliferator-activated Receptor (PPAR-y) CGCACTGGAATTAGATGACAGC CACAATCTGTCTGAGGTCTGTC 55°C 199 
Collagen type 1, alpha I (COL1A1) CGCGGATTTGTTGCTGCTTGC AGGTCCCATCAGCCCCATTGGT 55°C 269 
Aggrecan (ACAN) CGCTGTCTCGCCAAGTGTATGG CGGTTCAGGGATGCTGACACTC 60°C 175 
Glial Fibrillary Acidic Protein (GFAP) GGCACCTTGAGGCAGAAGCTC CTCCTGGAGCTCCCGCACCT 60°C 195 
Nestin (NES) ACCACTGAGCAGTTCCAGCTGG TTGCAGGTGTCTGCAGCCGT 55°C 187 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ATGAGATCAAGAAGGTGGTG CCAAATTCATTGTCGTACCAG 60°C 190 
 640 
 641 
 642 
 643 
 644 
 645 
 646 
 647 
 648 
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Figure Captions 649 
Figure 1. Cell characteristics. (A) Monolayer of WJ-derived cells (A); magnification 20X; scale 650 
bar= 20 µm. (B) growth curve at passages 1 (P1), 5 (P5) and 10 (P10); (C) doubling times for both 651 
fresh and thawed cells. (D) colony of WJ-derived cells for CFU study. Magnification: X 20; scale 652 
bar= 20 µm. 653 
 654 
Figure 2. (A) RT–PCR analysis of mesenchymal (CD29, CD44, CD105 and CD166), pluripotent 655 
(Oct-4 and c-Myc), hematopoietic (CD34 and CD14) specific gene expression on WJ-derived fresh 656 
and thawed cells. Major histocompatibility complex (MHC) I and II gene expression is also 657 
reported. GAPDH was used as the reference gene. (B) Flow cytometry analysis of the expression of 658 
mesenchymal (CD105 and CD166), hematopoietic (CD34) and immunogenic (MHCII) markers. 659 
Histograms represent relative number of cells vs. fluorescence intensity (FL1). Black histograms 660 
indicate background fluorescence intensity of cells labeled with isotype control antibodies only gray 661 
histograms show positivity to the studied antibodies.  662 
 663 
Figure 3. Staining of differentiated and control (undifferentiated) WJ-derived cells and respective 664 
molecular expression. Osteogenic induced cells were evaluated for von Kossa staining and RT–PCR 665 
analysis of SPP1, SPARC and BGLAP. Adipogenic induced cells were evaluated for Oil Red O-666 
stained cytoplasmic neutral lipids and RT–PCR of PPAR-γ and LEP. Chondrogenic induced cells 667 
were evaluated for Alcian blue staining and RT–PCR of COL2A1 and ACAN. Neurogenic induced 668 
cells were evaluated for Nissl staining and RT–PCR of NES and GFAP; magnification: X 20; scale 669 
bar=20 µm. GAPDH was employed as the reference gene. Bone, adipose tissue, cartilage and spinal 670 
cord were used as positive controls. 671 
 672 
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Bovine Wharton’s jelly (WJ)-derived cells were isolated for the first time by enzymatic method 
Molecular biology analyses revealed that these cells showed the CD antigen profile of MSCs  
These cells possessed ability to differentiate in mesodermic and ectodermic lines 
Their negativity to MHC-II reinforce the role of these cells as an allogenic source  
